BACKGROUND: Accuracy of familial risk assessment by endoscopists in determining colonoscopic screening and surveillance intervals is unknown. AIMS: To investigate follow-up recommended by endoscopists for individuals at average or increased familial risk, following colonoscopies that were normal or yielded hyperplastic polyps only. METHODS: Colonoscopy registry data was analyzed on 5,982 patients who had colonoscopy between 2004 and 2006. Patient information was linked with colonoscopy procedure information and pathology results. Patients with a personal or family history of colorectal cancer (CRC) or polyps, inflammatory bowel disease, or who had diagnostic, incomplete or suboptimally prepped examinations were excluded. The final analysis, which included 2,414 patients, investigated concordance of risk assessment between patient and endoscopist, and resulting endoscopist follow-up recommendations. RESULTS: Following normal colonoscopy, 76% of average risk individuals were told to follow-up in 10 years, but if a hyperplastic polyp was found, less than 10 years was suggested for 76%. Many patients reporting a known familial cancer syndrome or a very strong family history did not have that history indicated on the endoscopist's procedure form, and recommended follow-up intervals were beyond guideline recommendations for 60.4% of the very high-risk group. CONCLUSIONS: Endoscopists may sometimes be unaware of the presence of familial risk factors, even for individuals at very high familial risk. Greater consistency and accuracy in familial risk assessments could significantly increase the efficacy of screening in preventing colorectal cancer.
BACKGROUND: Accuracy of familial risk assessment by endoscopists in determining colonoscopic screening and surveillance intervals is unknown. AIMS: To investigate follow-up recommended by endoscopists for individuals at average or increased familial risk, following colonoscopies that were normal or yielded hyperplastic polyps only. METHODS: Colonoscopy registry data was analyzed on 5,982 patients who had colonoscopy between 2004 and 2006. Patient information was linked with colonoscopy procedure information and pathology results. Patients with a personal or family history of colorectal cancer (CRC) or polyps, inflammatory bowel disease, or who had diagnostic, incomplete or suboptimally prepped examinations were excluded. The final analysis, which included 2,414 patients, investigated concordance of risk assessment between patient and endoscopist, and resulting endoscopist follow-up recommendations. RESULTS: Following normal colonoscopy, 76% of average risk individuals were told to follow-up in 10 years, but if a hyperplastic polyp was found, less than 10 years was suggested for 76%. Many patients reporting a known familial cancer syndrome or a very strong family history did not have that history indicated on the endoscopist's procedure form, and recommended follow-up intervals were beyond guideline recommendations for 60.4% of the very high-risk group. CONCLUSIONS: Endoscopists may sometimes be unaware of the presence of familial risk factors, even for individuals at very high familial risk. Greater consistency and accuracy in familial risk assessments could significantly increase the efficacy of screening in preventing colorectal cancer.
Authors: Lynn Butterly; Christopher Olenec; Martha Goodrich; Patricia Carney; Allen Dietrich Journal: Am J Prev Med Date: 2006-12-20 Impact factor: 5.043
Authors: Madhusudhan R Sanaka; Dennis M Super; Edward S Feldman; Kevin D Mullen; D R Ferguson; Arthur J McCullough Journal: Gastrointest Endosc Date: 2006-01 Impact factor: 9.427
Authors: Sidney J Winawer; Ann G Zauber; Robert H Fletcher; Jonathon S Stillman; Michael J O'brien; Bernard Levin; Robert A Smith; David A Lieberman; Randall W Burt; Theodore R Levin; John H Bond; Durado Brooks; Tim Byers; Neil Hyman; Lynne Kirk; Alan Thorson; Clifford Simmang; David Johnson; Douglas K Rex Journal: CA Cancer J Clin Date: 2006 May-Jun Impact factor: 508.702
Authors: H J Järvinen; M Aarnio; H Mustonen; K Aktan-Collan; L A Aaltonen; P Peltomäki; A De La Chapelle; J P Mecklin Journal: Gastroenterology Date: 2000-05 Impact factor: 22.682
Authors: Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Michael J Thun Journal: CA Cancer J Clin Date: 2007 Jan-Feb Impact factor: 508.702
Authors: Vikram Boolchand; Gregory Olds; Joseph Singh; Pankaj Singh; Amitabh Chak; Gregory S Cooper Journal: Ann Intern Med Date: 2006-11-07 Impact factor: 25.391
Authors: Audrey H Calderwood; Joseph C Anderson; Christina M Robinson; Lynn F Butterly Journal: Am J Gastroenterol Date: 2018-11-02 Impact factor: 10.864
Authors: Mary Ann Greene; Lynn F Butterly; Martha Goodrich; Tracy Onega; John A Baron; David A Lieberman; Allen J Dietrich; Amitabh Srivastava Journal: Gastrointest Endosc Date: 2011-06-12 Impact factor: 9.427
Authors: Lynn Butterly; Christina M Robinson; Joseph C Anderson; Julia E Weiss; Martha Goodrich; Tracy L Onega; Christopher I Amos; Michael L Beach Journal: Am J Gastroenterol Date: 2014-01-07 Impact factor: 10.864
Authors: Joseph C Anderson; Lynn F Butterly; Christina M Robinson; Julia E Weiss; Christopher Amos; Amitabh Srivastava Journal: Gastroenterology Date: 2017-09-18 Impact factor: 22.682
Authors: Joseph C Anderson; Lynn F Butterly; Christina M Robinson; Martha Goodrich; Julia E Weiss Journal: Gastrointest Endosc Date: 2014-05-10 Impact factor: 9.427
Authors: Devin C Koestler; Jing Li; John A Baron; Gregory J Tsongalis; Lynn F Butterly; Martha Goodrich; Corina Lesseur; Margaret R Karagas; Carmen J Marsit; Jason H Moore; Angeline S Andrew; Amitabh Srivastava Journal: Mod Pathol Date: 2013-07-19 Impact factor: 7.842
Authors: Joseph C Anderson; Lynn F Butterly; Martha Goodrich; Christina M Robinson; Julia E Weiss Journal: Clin Gastroenterol Hepatol Date: 2013-05-06 Impact factor: 11.382